Health Catalyst Director Julie Larson-Green Receives 9,766 RSUs

What Happened
Julie Larson-Green, a director of Health Catalyst, Inc. (HCAT), was granted/received 9,766 restricted stock units (RSUs) on September 1, 2026. The Form 4 reports an acquisition at $0.00 per unit (total reported value $0). Per the filing, 100% of these RSUs vested on September 1, 2026; each RSU represents a contingent right to receive one share of common stock under the company’s 2019 Plan.

Key Details

• Transaction date: 2026-09-01 (reported on Form 4 filed 2026-09-03) — appears timely.
• Transaction type/code: Award/Grant (A) of 9,766 RSUs. Price reported: $0.00; reported acquisition value: $0.
• Shares owned after transaction: not specified in the information provided in this summary.
• Footnote: F1 — RSUs granted under the 2019 Stock Option and Incentive Plan; 100% vested on Sept 1, 2026 per the Non‑Employee Director Compensation Policy.
• No tax‑withholding, 10b5‑1 plan, or cashless sale details were reported in the provided footnote.

Context
RSUs are a form of compensation that convert to shares when they vest; this transaction reflects compensation/vesting for a director rather than an open‑market buy or sell. Such awards are routine for non‑employee directors and do not by themselves indicate buying or selling sentiment.